an innovator in non-invasive biomarker monitoring and the developer of a non-invasive glucose-monitoring wearable
Liom has raised €14M across 1 funding round from 4 investors, most recently a Series A round in Dec 2025. Based in Schwyz, Switzerland; active in Wellness & Beauty. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-19 | Series A | €14M |
| Alejo Costa Ribalta,Marc Maurer,Melih Odemis,Red Bull Ventures |
| View deal → |
